ADC Hero Image

A class of anticancer treatment, also known as ADCs, that are partially comprised of a monoclonal antibody. ADCs combine the selectiveness of targeted treatment with the potency of chemotherapy drugs.


Building "Smart Bombs" to Attack Cancer image

Building "Smart Bombs" to Attack Cancer

Biopharmaceutical researchers are investigating a new type of therapy that has the potential to attack cancer cells while leaving healthier cells unharmed.


Researcher Profile Nils Lonberg image

Researcher Profile: Nils Lonberg

In his role as senior vice president of oncology biology discovery at Bristol-Myers Squibb, Dr. Lonberg leads a drug discovery group responsible for identifying potential immuno-oncology (I-O) treatments.